Product Information
FT AD ALLERGY (CETRZN) 10 MG TB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0613 per EA under NDC 70677100704. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Jan 15, 2008.
Strength
10 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677100704
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078343FDA Approved
1/15/2008
On Market Since
5/12/2022
Pharmacological Classes
Price Statistics
The NADAC for FT AD ALLERGY (CETRZN) 10 MG TB has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 6.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0613 per EA |
|---|---|
| All-time high | $0.0721 (Dec 10, 2025) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0721 |
| 52-week low | $0.0611 |
| Median price | $0.0632 |
| Average price | $0.0636 |
| Largest weekly change | +24.2% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT AD ALLERGY (CETRZN) 10 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for FT AD ALLERGY (CETRZN) 10 MG TB, manufactured by Strategic Sourcing Services LLC, is $0.0613 per EA (NDC 70677100704), effective Sep 30, 2026.
How has the price of FT AD ALLERGY (CETRZN) 10 MG TB changed over time?
Over the history we have for it, the NADAC for FT AD ALLERGY (CETRZN) 10 MG TB has declined 6.4%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for FT AD ALLERGY (CETRZN) 10 MG TB?
Since Nov 8, 2023, the NADAC for FT AD ALLERGY (CETRZN) 10 MG TB has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0721 (Dec 10, 2025), with a median of $0.0632 per EA.
Are there cheaper alternatives to FT AD ALLERGY (CETRZN) 10 MG TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT AD ALLERGY (CETRZN) 10 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures FT AD ALLERGY (CETRZN) 10 MG TB?
FT AD ALLERGY (CETRZN) 10 MG TB (NDC 70677100704) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.